Mathias Ehrich

Mathias Ehrich is a seasoned professional in the field of medical science and research, currently serving as Chief Scientific Officer at Nucleix Ltd. since September 2023. With a strong entrepreneurial background, Mathias founded Juno Diagnostics in 2017, where responsibilities include leading research efforts. Prior experience includes a tenure at LabCorp as Chief Scientific Officer and Senior Vice President of Research and Development from 2016 to 2017, as well as a significant period at Sequenom from 2007 to 2016, where roles progressed from Senior Vice President and Chief Scientific Officer to various leadership positions in research and development. Mathias holds a Doctor of Medicine (MD) degree from the University of Hamburg, earned from 1994 to 2000.